首页 | 本学科首页   官方微博 | 高级检索  
     


Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation
Authors:Kühn Markus C  Willenberg Holger S  Schott Matthias  Papewalis Claudia  Stumpf Ulla  Flohé Sascha  Scherbaum Werner A  Schinner Sven
Affiliation:a Department of Endocrinology, Diabetes and Rheumatology, University Hospital Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany
b Department of Traumatology and Handsurgery, University Hospital Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany
Abstract:Several studies have reported a positive relationship of the body fat mass and bone density. However, it is not clear whether adipocyte-derived signaling molecules directly act on osteoblasts or osteoclasts. Therefore, we investigated the effect of fat cell-secreted factors on the proliferation and differentiation of preosteoblasts and the molecular mechanisms involved.This stimulation led to an increased proliferation of MC3T3-E1 and primary preosteoblastic cells (2.8-fold and 1.5-fold, respectively; < 0.0001), which could be reduced with inhibitors of protein tyrosine kinases, FGFR1 and PI3K. Concordantly, we found human adipocytes to secrete bFGF and bFGF to mimic the effect of adipocyte-secreted factors. The ratio of OPG/RANKL secretion in primary human preosteoblasts increased 9-fold (mRNA and protein) when stimulated with adipocyte-secreted factors. Moreover, osteoblasts which were prestimulated with adipocyte-secreted factors inhibited the formation of osteoclasts.In conclusion, human adipocytes secrete factors that directly act on preosteoblasts and alter their crosstalk with osteoclasts. These in vitro findings reflect the higher bone mass in obese people and attribute it to effects of adipocyte-secreted factors on bone formation.
Keywords:ALP, Alkaline phosphatase   bFGF, Basic fibroblast growth factor   BMI, Body mass index   BMD, Bone mineral density   CM, Control medium   DKK, Dickkopf   EGF, Epidermal growth factor   FCCM, Fat-cell conditioned-medium   FGFR1, Fibroblast growth factor receptor type 1   JAK, Janus kinase   LRP, Low density lipoprotein receptor-related protein   M-CSF, Macrophage colony-stimulating factor   MEK, MAPK/ERK kinase   OPG, Osteoprotegerin   PDGF, Platelet-derived growth factor   PI3K, Phosphatidylinositol-3-kinase   PKA, Protein kinase A   RANK, Receptor activator of nuclear factor kappa B   RANKL, Receptor activator of nuclear factor kappa B ligand   SFRP, Secreted frizzled-related protein   TRAP, Tartrate-resistant acid phosphatase
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号